Up and down waves of glycemic control and lower-extremity amputation in diabetes
Abstract Lower extremity amputations (LEA) are associated with a high mortality and medical expenditure. Diabetes accounts for 45% to 70% of LEA and is one of the most potent risk factors for peripheral artery diseases (PAD). The existence of a link between the recent relaxation of glycemic targets...
Main Authors: | Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Katherine Esposito, Dario Giugliano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Cardiovascular Diabetology |
Online Access: | https://doi.org/10.1186/s12933-021-01325-3 |
Similar Items
-
Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
by: Dario Giugliano, et al.
Published: (2021-01-01) -
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
by: Dario Giugliano, et al.
Published: (2021-09-01) -
Lower-Extremity Amputation: A 6-Year Follow-up Study in Brazil
by: JMP de Godoy, et al.
Published: (2005-08-01) -
Diabetes-related lower extremity amputations in Singapore
by: Yee Ang, et al.
Published: (2017-06-01) -
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
by: Miriam Longo, et al.
Published: (2020-07-01)